S-layer Protein Mediates the Stimulatory Effect of Lactobacillus Helveticus MIMLh5 on Innate Immunity
Overview
Microbiology
Authors
Affiliations
The ability to positively affect host health through the modulation of the immune response is a feature of increasing importance in measuring the probiotic potential of a bacterial strain. However, the identities of the bacterial cell components involved in cross talk with immune cells remain elusive. In this study, we characterized the dairy strain Lactobacillus helveticus MIMLh5 and its surface-layer protein (SlpA) using in vitro and ex vivo analyses. We found that MIMLh5 and SlpA exert anti-inflammatory effects by reducing the activation of NF-κB on the intestinal epithelial Caco-2 cell line. On the contrary, MIMLh5 and SlpA act as stimulators of the innate immune system by triggering the expression of proinflammatory factors tumor necrosis factor alpha and COX-2 in the human macrophage cell line U937 via recognition through Toll-like receptor 2. In the same experiments, SlpA protein did not affect the expression of the anti-inflammatory cytokine interleukin-10. A similar response was observed following stimulation of macrophages isolated from mouse bone marrow or the peritoneal cavity. These results suggest that SlpA plays a major role in mediating bacterial immune-stimulating activity, which could help to induce the host's defenses against and responses toward infections. This study supports the concept that the viability of bacterial cells is not always essential to exert immunomodulatory effects, thus permitting the development of safer therapies for the treatment of specific diseases according to a paraprobiotic intervention.
Duncan R, Mantegazza G, Gargari G, Pierallini E, Russo R, Guglielmetti S Probiotics Antimicrob Proteins. 2024; .
PMID: 39432229 DOI: 10.1007/s12602-024-10383-4.
Postbiotics in colorectal cancer: intervention mechanisms and perspectives.
Xie W, Zhong Y, Li X, Kang Y, Peng Q, Ying H Front Microbiol. 2024; 15:1360225.
PMID: 38450163 PMC: 10914944. DOI: 10.3389/fmicb.2024.1360225.
Nanobodies as potential tools for microbiological testing of live biotherapeutic products.
Dorosky R, Schreier J, Lola S, Sava R, Coryell M, Akue A AMB Express. 2024; 14(1):9.
PMID: 38245586 PMC: 10799837. DOI: 10.1186/s13568-023-01659-z.
Surface layer proteins from ATCC® 15009™ affect the gut barrier morphology and function.
Bendinelli P, De Noni I, Cattaneo S, Silvetti T, Brasca M, Piazzalunga F Tissue Barriers. 2023; 12(4):2289838.
PMID: 38059583 PMC: 11583618. DOI: 10.1080/21688370.2023.2289838.
S-layer proteins as immune players: Tales from pathogenic and non-pathogenic bacteria.
Assandri M, Malamud M, Trejo F, Serradell M Curr Res Microb Sci. 2023; 4:100187.
PMID: 37064268 PMC: 10102220. DOI: 10.1016/j.crmicr.2023.100187.